News Roundup: Rennova Health, Inc. (RNVA), General Electric Company (GE)


Rennova Health, Inc. (RNVA)

Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. The Company’s solutions include diagnostic solutions, revenue cycle management, healthcare software solutions, financial services, diagnostic laboratory testing and analytics for precision medicine, electronic health records and other software services. Rennova Health, Inc., formerly known as CollabRx, Inc., is headquartered in West Palm Beach, Florida.

Rennova Health, Inc. (RNVA)’s Financial Overview

Rennova Health, Inc. (RNVA) declined -21.65% yesterday to close its trading session at $0.02. The company has 1 year Price Target of $555. Rennova Health, Inc. has 52-Week high of $17.25 and 52-Week Low of $0.01. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 84.76 Million shares yesterday. The firm shows the market capitalization of $40000.

The firm is trading with SMA20 of 70.72 Percent, SMA50 of SMA50 Percent and SMA200 of -98.62 percent. Rennova Health, Inc. has P/S value of 0.02. Similarly, the company has Return on Assets of -301 percent, Return on Equity of 128.9 percent and Return on Investment of 1582.9 Percent.

The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 1 analysts offering 12-month price forecasts for Rennova Health Inc have a median target of 8,325.00, with a high estimate of 8,325.00 and a low estimate of 8,325.00. The median estimate represents a +36,513,057.89% increase from the last price of 0.02.

General Electric Company (GE)

General Electric Company operates as a technology and financial services company. Its segments include Energy Infrastructure, Aviation, Healthcare, Transportation, Home & Business Solutions and GE Capital. The company’s Energy Infrastructure segment offers wind turbines; gas and steam turbines and generators. Its Aviation segment offers jet engines, turboprop and turbo shaft engines, aerospace systems and equipment. Its Healthcare segment provides medical imaging and information technologies, medical diagnostics, patient monitoring systems. Its Transportation segment provides drive technology solutions to various industries. Its Home and Business Solutions segment provides home appliances; lighting products, plant automation, hardware, software, and embedded computing systems. Its GE Capital segment offers commercial loans and leases, fleet management, financial programs, credit cards, personal loans and other financial services. General Electric Company is headquartered in Fairfield, Connecticut.

General Electric Company (GE)‘s Financial Outlook

The 14 analysts offering 12-month price forecasts for General Electric Co have a median target of 16.00, with a high estimate of 27.00 and a low estimate of 11.00. The median estimate represents a +18.61% increase from the last price of 13.49.

According to Zacks Investment Research, General Electric Company has a Consensus Recommendation of 2.92. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock surged2.35% and closed its last trading session at $13.49. The company has the market capitalization of $120.46 Billion. The stock has 52-week high of $30.54 and 52-Week low of $12.73. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 69.91 Million shares. The company has a total of 8.93 Billion shares outstanding.

General Electric Company (GE) in the last quarter reported its actual EPS of $0.27/share where the analyst estimated EPS was $0.29/share. The difference between the actual and Estimated EPS is $-0.02. This shows a surprise factor of -6.9 percent.

The company has YTD performance of -22.69 percent. Beta for General Electric Company stands at 1.03 while its ATR (average true range) is 0.42. The company has Weekly Volatility of 2.08%% and Monthly Volatility of 3.23%.

General Electric Company has distance from 20-day Simple Moving Average (SMA20) of 0.59%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of -32.78%.

The Company currently has ROA (Return on Assets) of -1.7 percent, Return on Equity (ROE) of -8.6 Percent and Return on Investment (ROI) of -0.4% with Gross margin of 21.8 percent and Operating & Profit margin of -6.1% and -5.1% respectively.